13122-87-7COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1JFHROPTYMMSOLG-UHFFFAOYSA-NGSK-256066 is gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H330 (100%): Fatal if inhaled [Danger Acute toxicity, inhalation]
P260, P261, P271, P284, P304+P340, P316, P319, P320, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
VerwendenQuinoline derivative and a potential selective PDE4 phosphodiesterase inhibitor to treat prophylaxis or treatment of clinical conditions such as inflammatory or allergic diseases.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
13122-87-7、801312-28-7DTXSID30230090CHEMBL570015CHEBI:231666